FTC

FTC requests AbbVie, Allergan for more information on $63 billion deal
FTC requests AbbVie, Allergan for more information on $63 billion deal
Reuters
FTC
M&A
AbbVie
Allergan
Flag link:
U.S. Senators urge FTC to scrutinize multi-billion dollar pharma mergers
U.S. Senators urge FTC to scrutinize multi-billion dollar pharma mergers
Reuters
Senate
FTC
M&A
Flag link:
[podcast+transcript]Why Amgen's Spending Billions to Buy This 1 Drug
[podcast+transcript]Why Amgen's Spending Billions to Buy This 1 Drug
Motley Fool
FTC
Amgen
Celgene
Bristol-Myers Squibb
M&A
Otezla
Flag link:
Roche stays mum about FTC, CMA reviews as $4.3B Spark deal faces yet another delay. What's up?
Roche stays mum about FTC, CMA reviews as $4.3B Spark deal faces yet another delay. What's up?
Endpoints
Roche
Spark Therapeutics
FTC
CMA
M&A
Flag link:
Six burning Otezla questions
Six burning Otezla questions
EP Vantage
Celgene
Otezla
Amgen
drug pricing
FTC
Tyk2
Bristol-Myers Squibb
Flag link:
FTC investigates J&J contracts regarding the drugmaker's blockbuster Remicade
FTC investigates J&J contracts regarding the drugmaker's blockbuster Remicade
Endpoints
FTC
JNJ
Remicade
antitrust
biosimilars
Pfizer
Inflectra
Flag link:
Reckitt Benckiser Group PLC agrees to pay $1.4 billion to settle whistleblower cases
Reckitt Benckiser Group PLC agrees to pay $1.4 billion to settle whistleblower cases
CP Wire
whistleblower lawsuits
Reckitt Benckiser
FTC
opioids
opioid addiction
Suboxone
Flag link:
Reckitt Benckiser Group PLC agrees to pay $1.4 billion to settle whistleblower cases
whistleblower lawsuits
Reckitt Benckiser
FTC
opioids
opioid addiction
Suboxone
Flag link:
In surprise switch, Bristol-Myers is selling off blockbuster Otezla, promising to complete Celgene acquisition — just later
In surprise switch, Bristol-Myers is selling off blockbuster Otezla, promising to complete Celgene acquisition — just later
Endpoints
Bristol-Myers Squibb
Opdivo
Otezla
M&A
FTC
Celgene
Flag link:
FTC demands could mean months-long delay for Roche-Spark deal
FTC demands could mean months-long delay for Roche-Spark deal
Biopharma Dive
Roche
Spark Therapeutics
FTC
M&A
Flag link:
Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout
Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout
Endpoints
Spark Therapeutics
Roche
FTC
UK
M&A
Flag link:
Judge, CVS witness clash on merger settlement, July hearing set
Judge, CVS witness clash on merger settlement, July hearing set
Biopharma Dive
M&A
CVS Health
Aetna
FTC
Flag link:
Pay-for-delay deals disappearing, FTC says
Pay-for-delay deals disappearing, FTC says
Biopharma Dive
FTC
generics
pay-for-delay
Flag link:
FTC Finds Dwindling Number of Anticompetitive Reverse Payment Deals
FTC Finds Dwindling Number of Anticompetitive Reverse Payment Deals
RAPS.org
FTC
Hatch Waxman Act
anticompetitive practices
Flag link:
Roche delays $4.3B Spark buyout — again — as FTC review drags on
Roche delays $4.3B Spark buyout — again — as FTC review drags on
Endpoints
Roche
Spark Therapeutics
M&A
FTC
Flag link:
Impax in hot water for 'pay-for-delay' deal on Endo painkiller Opana ER, feds say
Impax in hot water for 'pay-for-delay' deal on Endo painkiller Opana ER, feds say
Fierce Pharma
FTC
pay-for-delay
Impax Laboratories
Endo
Amneal
Opana ER
Flag link:
Bristol-Myers Gets FTC Request for More Information on $74 Billion Celgene Deal
Bristol-Myers Gets FTC Request for More Information on $74 Billion Celgene Deal
TheStreet.com
SEC
FTC
M&A
Bristol-Myers Squibb
Celgene
Flag link:
Trump to sign law allowing FTC to scrutinize biosimilar deals
Trump to sign law allowing FTC to scrutinize biosimilar deals
Biopharma Dive
Donald Trump
biosimilars
antitrust
FTC
Flag link:
FTC Clears Takeda's Acquisition of Shire
FTC Clears Takeda's Acquisition of Shire
CP Wire
FTC
M&A
Takeda
Shire
Flag link:
Watch out, Allergan. Activist investor David Tepper won approval to push a shake-up
Watch out, Allergan. Activist investor David Tepper won approval to push a shake-up
Fierce Pharma
investors
Allergan
David Tepper
FTC
Flag link:

Pages